Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Torley Helen
Relationship:   Director
City:   South San Francisco
State:   CA
   
Insider Summary:
  
   
Companies Owned :   4    
Direct Shares   683,004    

Indirect Shares

   0      
Direct Value   $31,666,361    

Indirect Value

   $0      
Total Shares   683,004      
Total Value   $31,666,361      


Halozyme Therapeutics Inc $30,778,317 Quest Diagnostics Inc $888,044 Halozyme Therapeutics Inc $30,778,317 Quest Diagnostics Inc $888,044
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    2    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    2    
   
     Gain/Loss Ratio :
   0.0   
   -2.0   
     Percentage Gain/Loss :
     0.0%
 -28.8%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Onyx Pharmaceuticals Inc ONXX EVP, Chief Commercial ... 2013-10-01 0 2011-08-29 0    Premium*  
            Halozyme Therapeutics Inc HALO 2024-02-16 676,744 2014-09-16 0    Premium*  
            Relypsa Inc RLYP Director 2016-09-01 0 2015-06-04 0    Premium*  
            Quest Diagnostics Inc DGX Director 2021-05-25 6,260 2018-05-15 0    Premium*  
* Premium Members only  

Records found :    169         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 6 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
HALO Halozyme Therapeutics Inc PRESIDENT AND CEO   •       •      –    2023-01-19 4 AS $52.41 $524,140 D/D (10,000) 587,177 0 %
HALO Halozyme Therapeutics Inc PRESIDENT AND CEO   •       •      –    2022-11-16 4 AS $53.90 $538,990 D/D (10,000) 587,177 0 %
HALO Halozyme Therapeutics Inc PRESIDENT AND CEO   •       •      –    2022-11-15 4 AS $54.11 $541,146 D/D (10,000) 587,177 0 %
HALO Halozyme Therapeutics Inc PRESIDENT AND CEO   •       •      –    2023-02-16 4 S $49.26 $544,865 D/D (11,061) 633,666 0 %
HALO Halozyme Therapeutics Inc PRESIDENT AND CEO   •       •      –    2022-12-15 4 AS $57.29 $573,694 D/D (10,000) 587,177 0 %
HALO Halozyme Therapeutics Inc President and CEO   •       •      –    2022-02-10 4 D $34.94 $579,934 D/D (16,598) 551,844 0 -
HALO Halozyme Therapeutics Inc PRESIDENT AND CEO   •       •      –    2022-12-14 4 AS $58.30 $582,980 D/D (10,000) 587,177 0 %
HALO Halozyme Therapeutics Inc PRESIDENT AND CEO   •       •      –    2022-12-13 4 AS $58.64 $586,627 D/D (10,000) 587,177 0 %
HALO Halozyme Therapeutics Inc President and CEO   •       •      –    2022-02-12 4 D $34.20 $590,497 D/D (17,266) 567,373 0 -
HALO Halozyme Therapeutics Inc PRESIDENT AND CEO   •       •      –    2024-02-10 4 D $35.49 $601,307 D/D (16,943) 638,004 0 -
ONXX Onyx Pharmaceuticals Inc EVP, Chief Commercial Officer   •       –      –    2013-02-04 4 AS $78.61 $648,533 D/D (8,250) 39,512 0 -
HALO Halozyme Therapeutics Inc President and CEO   •       •      –    2021-02-14 4 D $49.84 $709,871 D/D (14,243) 517,317 0 -
HALO Halozyme Therapeutics Inc President and CEO   •       •      –    2020-11-25 4 OE $14.66 $733,000 D/D 50,000 530,522 0 -
HALO Halozyme Therapeutics Inc President and CEO   •       •      –    2021-02-01 4 OE $14.66 $733,000 D/D 50,000 520,522 0 -
HALO Halozyme Therapeutics Inc President and CEO   •       •      –    2021-03-01 4 OE $14.66 $733,000 D/D 50,000 587,160 0 -
HALO Halozyme Therapeutics Inc President and CEO   •       •      –    2021-05-11 4 OE $14.66 $733,000 D/D 50,000 587,160 0 -
HALO Halozyme Therapeutics Inc President and CEO   •       •      –    2021-06-07 4 OE $14.66 $733,000 D/D 50,000 587,160 0 -
HALO Halozyme Therapeutics Inc President and CEO   •       •      –    2021-07-06 4 OE $14.66 $733,000 D/D 50,000 587,160 0 -
HALO Halozyme Therapeutics Inc President and CEO   •       •      –    2021-08-10 4 OE $14.66 $733,000 D/D 50,000 587,160 0 -
HALO Halozyme Therapeutics Inc President and CEO   •       •      –    2021-09-07 4 OE $14.66 $733,000 D/D 50,000 587,160 0 -
HALO Halozyme Therapeutics Inc President and CEO   •       •      –    2021-10-04 4 OE $14.66 $733,000 D/D 50,000 587,160 0 -
HALO Halozyme Therapeutics Inc President and CEO   •       •      –    2021-11-08 4 OE $14.66 $733,000 D/D 50,000 587,160 0 -
HALO Halozyme Therapeutics Inc PRESIDENT AND CEO   •       •      –    2024-02-16 4 D $36.10 $735,068 D/D (20,362) 676,744 0 -
HALO Halozyme Therapeutics Inc President and CEO   •       •      –    2021-02-10 4 D $50.60 $784,755 D/D (15,509) 486,295 0 -
HALO Halozyme Therapeutics Inc PRESIDENT AND CEO   •       •      –    2023-02-10 4 D $48.92 $805,663 D/D (16,469) 601,989 0 -
  169  Records found
  1   2   3   4   5   6  7      
  Page 6 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us